LP15163-6

Amobarbital

Active

Description

Barbiturates were first developed in 1864 by Adolf von Baeyer and were widely distributed by the Farbwerke Fr Bayer and Co in 1904. Barbiturates offered new treatment to patients with psychiatric and neurological disorders profoundly improving their prognoses. Barbiturates were also used to treat sleep disorders and were the first drugs to effectively treat epileptic seizures. Due to safety concerns related to drug dependence and overdose and new safer psychoactive medications barbiturate use sharply declined in the 1950s. PMID: 18568113 Amobarbital is a barbiturate that is used as a hypnotic and sedative. Physical effects include central nervous system depression and dependence when dosage levels are high. [PubChem: amobarbital] Source: Regenstrief LOINC

Basic Part Properties

Part Display Name

Amobarbital

Part Type

Component (Describes the core component or analyte measured)

Created On

2000-05-04

Construct for LOINC Short Name

Amobarbital

Related Codes

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.

CodeSystem lookup

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP15163-6

ConceptMap translate

https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP15163-6

Language Variants Get Info

LOINC Copyright

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.